Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Brouwer

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|August 8, 2022
End-of-treatment HBsAg, HBcrAg and HBV RNA predict the risk of off-treatment ALT flares in chronic hepatitis B patientsSylvia M Brakenhoff, Robert J de Knegt, Margo J H van Campenhout, et al.
The Lancet. Gastroenterology & Hepatology|April 13, 2019
Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B studyMilan J Sonneveld, Willem P Brouwer, Henry L-Y Chan, et al.
Nature Communications|May 31, 2014
Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerancePatricia E de Almeida, Everett H Meyer, Nigel G Kooreman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 25, 2025
The Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis BLesley A Patmore, Kirsi van Eekhout, Özgür M Koc, et al.
Scientific Reports|March 27, 2024
The C-type lectin DCIR contributes to the immune response and pathogenesis of colorectal cancerGiulia Trimaglio, Tamara Sneperger, Benjamin B A Raymond, et al.
The Journal of Infectious Diseases|April 23, 2020
Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B StudyMilan J Sonneveld, Bettina E Hansen, Willem P Brouwer, et al.
Alimentary Pharmacology & Therapeutics|September 4, 2020
Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosisMilan J Sonneveld, Willem P Brouwer, Bettina E Hansen, et al.
AJNR. American Journal of Neuroradiology|October 30, 2020
Considerations for Antiplatelet Management of Carotid Stenting in the Setting of Mechanical Thrombectomy: A Delphi Consensus StatementM Goyal, S Yoshimura, G Milot, et al.
Alimentary Pharmacology & Therapeutics|July 3, 2018
A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis BR El Sharkawy, K Thabet, P Lampertico, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 23, 2016
Hepatitis B core-related antigen levels are associated with response to entecavir and peginterferon add-on therapy in hepatitis B e antigen-positive chronic hepatitis B patientsM J H van Campenhout, W P Brouwer, G W van Oord, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|August 8, 2022
End-of-treatment HBsAg, HBcrAg and HBV RNA predict the risk of off-treatment ALT flares in chronic hepatitis B patientsSylvia M Brakenhoff, Robert J de Knegt, Margo J H van Campenhout, et al.
The Lancet. Gastroenterology & Hepatology|April 13, 2019
Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B studyMilan J Sonneveld, Willem P Brouwer, Henry L-Y Chan, et al.
Nature Communications|May 31, 2014
Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerancePatricia E de Almeida, Everett H Meyer, Nigel G Kooreman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 25, 2025
The Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis BLesley A Patmore, Kirsi van Eekhout, Özgür M Koc, et al.
Scientific Reports|March 27, 2024
The C-type lectin DCIR contributes to the immune response and pathogenesis of colorectal cancerGiulia Trimaglio, Tamara Sneperger, Benjamin B A Raymond, et al.
The Journal of Infectious Diseases|April 23, 2020
Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B StudyMilan J Sonneveld, Bettina E Hansen, Willem P Brouwer, et al.
Alimentary Pharmacology & Therapeutics|September 4, 2020
Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosisMilan J Sonneveld, Willem P Brouwer, Bettina E Hansen, et al.
AJNR. American Journal of Neuroradiology|October 30, 2020
Considerations for Antiplatelet Management of Carotid Stenting in the Setting of Mechanical Thrombectomy: A Delphi Consensus StatementM Goyal, S Yoshimura, G Milot, et al.
Alimentary Pharmacology & Therapeutics|July 3, 2018
A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis BR El Sharkawy, K Thabet, P Lampertico, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 23, 2016
Hepatitis B core-related antigen levels are associated with response to entecavir and peginterferon add-on therapy in hepatitis B e antigen-positive chronic hepatitis B patientsM J H van Campenhout, W P Brouwer, G W van Oord, et al.
Pageof 13